UK, med-tech company, Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation.
Bedfont's NObreath monitor for airway inflammation has been cleared for sale in the USA MAIDSTONE, England, Jan. 31, 2022 /PRNewswire/ UK, med-tech company, Bedfont Scientific Ltd.,